History of the Concept of Disconnectivity in Schizophrenia
- 1 March 2016
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Harvard Review of Psychiatry
- Vol. 24 (2), 80-86
- https://doi.org/10.1097/hrp.0000000000000102
Abstract
Nearly 60 years ago Seymour Kety proposed that research on genetics and brain pathology, but not on neurochemistry, would ultimately lead to an understanding of the pathophysiology of schizophrenia. This article will demonstrate the prescience of Kety’s proposal; advances in our knowledge of brain structure and genetics have shaped our current understanding of the pathophysiology of schizophrenia. Brain-imaging techniques have shown that schizophrenia is associated with cortical atrophy and ventricular enlargement, which progresses for at least a decade after the onset of psychotic symptoms. Cortical atrophy correlates with negative symptoms and cognitive impairment, but not with psychotic symptoms, in schizophrenia. Studies with the Golgi-staining technique that illuminates the entire neuron indicate that cortical atrophy is due to reduced synaptic connectivity on the pyramidal neurons and not due to actual loss of neurons. Results of recent genetic studies indicate that several risk genes for schizophrenia are within two degrees of separation from the N-methy-D-aspartate receptor (NMDAR), a subtype of glutamate receptor that is critical to synapse formation and synaptic plasticity. Inactivation of one of these risk genes that encodes serine racemase, which synthesizes D-serine, an NMDAR co-agonist, reproduces the synaptic pathology of schizophrenia. Thus, widespread loss of cortical synaptic connectivity appears to be the primary pathology in schizophrenia that is driven by multiple risk genes that adversely affect synaptogenesis and synapse maintenance, as hypothesized by Kety.Keywords
This publication has 72 references indexed in Scilit:
- Neuronal d-serine regulates dendritic architecture in the somatosensory cortexNeuroscience Letters, 2012
- The NMDA receptor co-agonists, d-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortexNeurobiology of Disease, 2012
- De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophreniaMolecular Psychiatry, 2011
- Progressive Brain Change in Schizophrenia: A Prospective Longitudinal Study of First-Episode SchizophreniaBiological Psychiatry, 2011
- Long-term Antipsychotic Treatment and Brain VolumesArchives of General Psychiatry, 2011
- Evidence for Abnormal Forward Trafficking of AMPA Receptors in Frontal Cortex of Elderly Patients with SchizophreniaNeuropsychopharmacology, 2010
- Diffusion tensor tractography findings in schizophrenia across the adult lifespanBrain, 2010
- The role of SAP97 in synaptic glutamate receptor dynamicsProceedings of the National Academy of Sciences of the United States of America, 2010
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaTrends in Neurosciences, 2008
- Reduced Dendritic Spine Density in Auditory Cortex of Subjects with SchizophreniaNeuropsychopharmacology, 2008